2m 2m 2m 2m 2m 2m 2m
INNOVAGE HLDG (INNV)
NASDAQ
$10.74-$0.010 (-0.09%)
Price as of Sep 11, 2026 7:32 PM EDT- $1.5BMarket Cap
- 136.26%1-Year Change
- Medical Care FacilitiesIndustry
INNOVAGE HLDG (INNV)
$10.74-$0.010 (-0.09%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 988.4M +15.96% | 852.4M +11.59% | 763.9M +11.01% | 688.1M -1.51% | |
Cost of Revenue | 312.1M +16.06% | 268.9M +17.54% | 228.8M +7.78% | 212.3M +17.78% | |
Gross Profit | 227.6M +48.57% | 153.2M +16.02% | 132.1M +30.38% | 101.3M -25.22% | |
Sales and Marketing Expense | 34.4M +21.77% | 28.2M +13.06% | 25.0M +27.16% | 19.6M -18.90% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 21.1M +8.36% | 19.5M +2.96% | 18.9M +22.90% | 15.4M +10.74% | |
Total Operating Expenses | 987.1M +11.73% | 883.5M +12.25% | 787.0M +6.72% | 737.5M +4.90% | |
Operating Profit | 2.6M +108.80% | -29.8M +28.39% | -23.2M -53.07% | -49.4M +1,021.08% | |
Interest Income | N/A N/A | N/A N/A | 2.5M N/A | N/A N/A | |
Interest Expense | -4.3M -7.68% | -4.6M +14.64% | -4.0M +164.32% | -1.5M -39.75% | |
Interest Income and Expense and Net | -4.3M -7.68% | -4.6M +211.41% | -1.5M -2.69% | -1.5M -39.75% | |
Total Nonoperating Income and Expense | -2.4M -44.87% | -4.3M -413.45% | 1.4M +197.35% | -1.4M -50.62% | |
Income before Taxes | 266,000 +100.78% | -34.0M +55.95% | -21.8M -57.04% | -50.8M +601.85% | |
Income Taxes | 949,000 -27.89% | 1.3M -6.13% | 1.4M +119.36% | -7.2M -1,101.52% | |
Extraordinary Items | N/A N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -2.5M -91.63% | -30.3M +42.06% | -21.3M -47.54% | -40.7M +523.72% | |
Net Income from Continuing Operations Applicable to Common | -2.5M -91.63% | -30.3M +42.06% | -21.3M -47.54% | -40.7M +523.72% | |
Basic EPS and Net Income | -0.02 -90.91% | -0.22 +37.50% | -0.16 -46.67% | -0.30 +500.00% | |
Diluted EPS and Net Income | -0.02 -90.91% | -0.22 +37.50% | -0.16 -46.67% | -0.30 +500.00% | |
Basic Weighted Average Shares | 135.7M +0.23% | 135.4M -0.38% | 135.9M +0.23% | 135.6M +0.05% | |
Diluted Weighted Average Shares | 135.7M +0.23% | 135.4M -0.38% | 135.9M +0.23% | 135.6M +0.05% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 97.9M +2,959.09% | 3.2M -94.38% | 56.9M -55.25% | 127.2M -31.00% | |
Short-Term Investments | 43.4M +3.97% | 41.8M -8.85% | 45.8M -0.82% | 46.2M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 141.3M +214.23% | 45.0M -56.24% | 102.8M -40.75% | 173.5M -5.95% | |
Total Current Assets | 214.3M +21.69% | 176.1M +1.71% | 173.1M -19.55% | 215.2M -10.68% | |
Accumulated Depreciation | 115.3M +16.79% | 98.8M +12.98% | 87.4M +23.69% | 70.7M +23.81% | |
Property and Plant and Equipment and Net | 166.1M -1.17% | 168.0M -12.94% | 193.0M +0.43% | 192.2M +9.04% | |
Total Long-Term Assets | 343.1M -2.18% | 350.7M -6.35% | 374.5M +6.36% | 352.1M +11.91% | |
Total Assets | 557.4M +5.80% | 526.9M -3.80% | 547.7M -3.47% | 567.4M +2.12% | |
Income Taxes Payable | 9.1M +3.31% | 8.8M +17.44% | 7.5M +0.16% | 7.4M -58.07% | |
Total Short-Term Debt | 2.5M +12.71% | 2.3M -40.71% | 3.8M 0.00% | 3.8M +0.05% | |
Total Current Liabilities | 203.9M +23.72% | 164.8M +18.91% | 138.6M -6.64% | 148.4M +40.97% | |
Total Long-Term Debt | 45.5M -20.78% | 57.5M -6.53% | 61.5M -5.19% | 64.8M -4.93% | |
Total Long-Term Liabilities | 2.1M +45.95% | 1.5M +12.33% | 1.3M +19.52% | 1.1M -4.23% | |
Total Liabilities | 288.6M +9.35% | 263.9M +6.49% | 247.9M -1.86% | 252.6M +25.12% | |
Retained Earnings | -105.8M +4.66% | -101.0M +47.92% | -68.3M +90.05% | -35.9M -860.08% | |
Total Stockholders Equity | 235.6M +0.27% | 235.0M -12.74% | 269.3M -9.13% | 296.3M -10.85% | |
Total Shares Outstanding | 136.0M +0.43% | 135.4M -0.50% | 136.1M +0.35% | 135.6M +0.08% | |
Cash Flow | |||||
Cash from Operating Activities | 64.7M +96.90% | 32.9M +189.07% | -36.9M -282.34% | 20.2M -25.88% | |
Capital Expenditures | 14.3M +128.47% | 6.3M -20.86% | 7.9M -66.11% | 23.4M -38.92% | |
Cash from Investing Activities | -12.3M +122.34% | -5.5M -78.96% | -26.4M -62.06% | -69.5M +72.77% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -18.5M -2.89% | -19.1M +171.28% | -7.0M -10.92% | -7.9M +24.98% | |
Financials Ratio | |||||
Gross Margin | 68.42% -0.04% | 68.45% -2.28% | 70.05% +1.30% | 69.15% -6.81% | |
Operating Margin | 0.26% +107.59% | -3.49% +15.06% | -3.03% -57.73% | -7.18% +1,038.20% | |
Return on Assets | -0.47% -91.71% | -5.64% +47.42% | -3.83% -47.16% | -7.24% +503.96% | |
Return on Equity | -1.08% -91.03% | -12.02% +59.34% | -7.55% -41.68% | -12.94% +562.27% | |
Revenue Growth | 15.96% +37.75% | 11.59% +5.22% | 11.01% +828.99% | -1.51% -115.83% | |
Current Ratio | 1.05 -1.64% | 1.07 -14.46% | 1.25 -13.84% | 1.45 -36.64% | |
Cash Ratio | 0.48 +2,374.74% | 0.02 -95.28% | 0.41 -52.06% | 0.86 -51.05% | |
Debt-to-Equity Ratio | 0.20 -19.72% | 0.25 +4.83% | 0.24 +4.62% | 0.23 +6.97% | |
Debt-to-Assets Ratio | 0.09 -23.92% | 0.11 -4.95% | 0.12 -1.49% | 0.12 -6.64% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow